"Nyxoah SA (Nyxoah), a medical technology company that develops breakthrough treatment alternatives for obstructive sleep apnoea (OSA) through neuromodulation, announced the commercial launch of its Genio system in England, marked by the first successful implants performed at University College London Hospitals (UCLH).
Genio is now covered under the NHS Specialised Services Devices Programme (SSDP), enabling access to innovative therapies through specialized centres of excellence.
The first two patients were successfully implanted by Ryan Chin Taw Cheong, consultant ENT and sleep surgeon at UCLH. Commenting on the milestone, Cheong said: “We are proud to be the first hospital in the UK to offer Genio to our OSA patients. Genio is a groundbreaking, clinically proven therapy that addresses the unmet needs of individuals suffering from obstructive sleep apnoea.”
Olivier Taelman, CEO of Nyxoah, added: “Today represents an important milestone for Nyxoah as we introduce our Genio neurostimulation solution to treat obstructive sleep apnoea in England. Congratulations to Cheong and his team on this remarkable achievement. We look forward to expanding our collaboration with UCLH and other leading hospitals in England as we continue our mission to make sleep simple for OSA patients.”
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnoea (OSA). The company is a medical technology company that develops breakthrough treatment alternatives for OSA through neuromodulation."
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!